Cost-Effectiveness of Treating Multidrug-Resistant Tuberculosis
Resch and colleagues found that treatment of MDR TB using second-line drugs is highly cost-effective in Peru.
| Main Authors: | , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Public Library of Science
2006
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483913/ |